Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETANERCEPT Cause Upper respiratory tract infection? 2,948 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 2,948 reports of Upper respiratory tract infection have been filed in association with ETANERCEPT (ENBREL). This represents 0.8% of all adverse event reports for ETANERCEPT.

2,948
Reports of Upper respiratory tract infection with ETANERCEPT
0.8%
of all ETANERCEPT reports
341
Deaths
346
Hospitalizations

How Dangerous Is Upper respiratory tract infection From ETANERCEPT?

Of the 2,948 reports, 341 (11.6%) resulted in death, 346 (11.7%) required hospitalization, and 145 (4.9%) were considered life-threatening.

Is Upper respiratory tract infection Listed in the Official Label?

Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for ETANERCEPT.

What Other Side Effects Does ETANERCEPT Cause?

Drug ineffective (60,367) Rheumatoid arthritis (33,166) Pain (31,961) Arthralgia (27,429) Injection site pain (24,717) Off label use (20,178) Fatigue (19,907) Joint swelling (18,462) Injection site erythema (17,736) Condition aggravated (15,897)

What Other Drugs Cause Upper respiratory tract infection?

ADALIMUMAB (3,306) TOFACITINIB (1,805) RITUXIMAB (1,713) ABATACEPT (1,623) METHOTREXATE (1,576) TOCILIZUMAB (1,455) APREMILAST (1,437) PREDNISONE (1,354) SECUKINUMAB (1,339) LENALIDOMIDE (1,334)

Which ETANERCEPT Alternatives Have Lower Upper respiratory tract infection Risk?

ETANERCEPT vs ETANERCEPT-SZZS ETANERCEPT vs ETELCALCETIDE ETANERCEPT vs ETEPLIRSEN ETANERCEPT vs ETESEVIMAB ETANERCEPT vs ETHACRYNIC ACID

Related Pages

ETANERCEPT Full Profile All Upper respiratory tract infection Reports All Drugs Causing Upper respiratory tract infection ETANERCEPT Demographics